Tirzepatide is a different drug with two active components: GLP-1 and GIP (both hormones involved in blood sugar and appetite regulation)
They are used in the treatment of both Type 2 diabetes and obesity
It does not go through the same quality testing, and dosing can vary between batches
A result obtained by rubbing a peptide on skin does not transfer to putting it into tissue or bloodstream, where dose, distribution, and copper load are all different
"In my practice, GLP-1s are one of the tools I use for improving metabolic health, says Daniel McGee, D.O., a board-certified family medicine physician, The cardiovascular data has been encouraging, and in the right patients theyre usually well tolerated and can really help make a difference when combined with lifestyle changes." There are a few reasons why GLP-1 medications influence the cardiovascular system: Weight loss: Obesity and being overweight are risk factors for heart disease